Genenta Science S.p.A. Cash and Cash Equivalents
Genenta Science S.p.A. (GNTA) had Cash and Cash Equivalents of EUR 5.53 million as of 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-04-01
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value 5.53M EUR.
- 2025-06-30: Cash and Cash Equivalents, at Carrying Value 5.18M EUR.
- 2024-12-31: Cash and Cash Equivalents, at Carrying Value 4.58M EUR.
- 2024-06-30: Cash and Cash Equivalents, at Carrying Value 6.19M EUR.
EUR
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2025-12-31 | 5.53M EUR 20-F · filed 2026-04-01 |
| 2025-06-30 | 5.18M EUR 6-K · filed 2025-10-10 |
| 2024-12-31 | 4.58M EUR 20-F · filed 2026-04-01 |
| 2024-06-30 | 6.19M EUR 6-K · filed 2024-10-29 |
| 2023-12-31 | 3.69M EUR 20-F · filed 2026-04-01 |
| 2023-06-30 | 12.21M EUR 6-K · filed 2023-10-20 |
| 2022-12-31 | 29.79M EUR 20-F · filed 2025-03-28 |
| 2022-06-30 | 34.67M EUR 6-K · filed 2022-10-25 |
| 2021-12-31 | 37.24M EUR 20-F · filed 2024-03-29 |
| 2020-12-31 | 15.47M EUR 20-F · filed 2022-05-02 |
USD
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2021-12-31 | $25.70M 20-F · filed 2022-05-02 |